Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Verrone

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 26, 2023
Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 yearsL Mastorino, P Dapavo, L Burzi, et al.
European Review for Medical and Pharmacological Sciences|July 30, 2015
Feasibility of office CO2 laser surgery in patients affected by benign pathologies and congenital malformations of female lower genital tractA Frega, A Verrone, M Schimberni, et al.
European Review for Medical and Pharmacological Sciences|November 11, 2016
Expression of E6/E7 HPV-DNA, HPV-mRNA and colposcopic features in management of CIN2/3 during pregnancyA Frega, A Verrone, F Manzara, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2021
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patientsC Cariti, P Dapavo, L Mastorino, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 13, 2016
New insights into potential risk factors and associations in genital lichen sclerosus: Data from a multicentre Italian study on 729 consecutive casesA Virgili, A Borghi, S Cazzaniga, et al.
The Science of the Total Environment|January 8, 2020
Increasing market opportunities for renewable energy technologies with innovations in aquifer thermal energy storageN Hoekstra, M Pellegrini, M Bloemendal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 10, 2022
Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patientsL Mastorino, F Castelli, E Stroppiana, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 26, 2023
Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 yearsL Mastorino, P Dapavo, L Burzi, et al.
European Review for Medical and Pharmacological Sciences|July 30, 2015
Feasibility of office CO2 laser surgery in patients affected by benign pathologies and congenital malformations of female lower genital tractA Frega, A Verrone, M Schimberni, et al.
European Review for Medical and Pharmacological Sciences|November 11, 2016
Expression of E6/E7 HPV-DNA, HPV-mRNA and colposcopic features in management of CIN2/3 during pregnancyA Frega, A Verrone, F Manzara, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2021
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patientsC Cariti, P Dapavo, L Mastorino, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 13, 2016
New insights into potential risk factors and associations in genital lichen sclerosus: Data from a multicentre Italian study on 729 consecutive casesA Virgili, A Borghi, S Cazzaniga, et al.
The Science of the Total Environment|January 8, 2020
Increasing market opportunities for renewable energy technologies with innovations in aquifer thermal energy storageN Hoekstra, M Pellegrini, M Bloemendal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 10, 2022
Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patientsL Mastorino, F Castelli, E Stroppiana, et al.
Pageof 2